Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

about

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

Item

http://www.wikidata.org/entity/Q38962101

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

@en

type

Item

label

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

@en

prefLabel

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

@en

P1476

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

@en

P2093

Amy Sobbe

http://www.w3.org/2001/XMLSchema#string

C Erika de Guzman

http://www.w3.org/2001/XMLSchema#string

Catherine M Campbell

http://www.w3.org/2001/XMLSchema#string

Darrell H G Crawford

http://www.w3.org/2001/XMLSchema#string

Kim R Bridle

http://www.w3.org/2001/XMLSchema#string

Lesley Jaskowski

http://www.w3.org/2001/XMLSchema#string

Nishreen Santrampurwala

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia

Deferasirox

Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil

The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.

Adipocyte iron regulates adiponectin and insulin sensitivity.

Deferasirox for transfusion-related iron overload: a clinical review.

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia

The pathology of hepatic iron overload: a free radical--mediated process?

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

P304

638-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JGH.12720

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew D. Clouston

Nathan V Subramaniam

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25168203

http://www.w3.org/2001/XMLSchema#string